213 related articles for article (PubMed ID: 33158280)
1. Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice.
Ponikwicka-Tyszko D; Chrusciel M; Pulawska K; Bernaczyk P; Sztachelska M; Guo P; Li X; Toppari J; Huhtaniemi IT; Wołczyński S; Rahman NA
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158280
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.
Ponikwicka-Tyszko D; Chrusciel M; Stelmaszewska J; Bernaczyk P; Chrusciel P; Sztachelska M; Scheinin M; Bidzinski M; Szamatowicz J; Huhtaniemi IT; Wolczynski S; Rahman NA
EBioMedicine; 2019 Sep; 47():170-183. PubMed ID: 31466918
[TBL] [Abstract][Full Text] [Related]
3. New Insights on the Progesterone (P4) and PGRMC1/NENF Complex Interactions in Colorectal Cancer Progression.
Kamińska J; Koper-Lenkiewicz OM; Ponikwicka-Tyszko D; Lebiedzińska W; Palak E; Sztachelska M; Bernaczyk P; Dorf J; Guzińska-Ustymowicz K; Zaręba K; Wołczyński S; Rahman NA; Dymicka-Piekarska V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894441
[TBL] [Abstract][Full Text] [Related]
4. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
Sueldo C; Liu X; Peluso JJ
Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
[TBL] [Abstract][Full Text] [Related]
5. PGRMC1 and PGRMC2 in uterine physiology and disease.
Pru JK; Clark NC
Front Neurosci; 2013; 7():168. PubMed ID: 24065879
[TBL] [Abstract][Full Text] [Related]
6. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
7. Dominant role of nuclear progesterone receptor in the control of rat periovulatory granulosa cell apoptosis.
Friberg PA; Larsson DG; Billig H
Biol Reprod; 2009 Jun; 80(6):1160-7. PubMed ID: 19208546
[TBL] [Abstract][Full Text] [Related]
8. Association between progesterone and estradiol-17beta treatment and protein expression of pgr and PGRMC1 in porcine luminal epithelial cells: a real-time cell proliferation approach.
Kempisty B; Wojtanowicz-Markiewicz K; Ziółkowska A; Budna J; Ciesiółka S; Piotrowska H; Bryja A; Antosik P; Bukowska D; Wollenhaupt K; Bruska M; Brüssow KP; Nowicki M; Zabel M
J Biol Regul Homeost Agents; 2015; 29(1):39-50. PubMed ID: 25864740
[TBL] [Abstract][Full Text] [Related]
9. Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type.
El-Hefnawy T; Manna PR; Luconi M; Baldi E; Slotte JP; Huhtaniemi I
Endocrinology; 2000 Jan; 141(1):247-55. PubMed ID: 10614645
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
Clark NC; Friel AM; Pru CA; Zhang L; Shioda T; Rueda BR; Peluso JJ; Pru JK
Cancer Biol Ther; 2016; 17(3):262-71. PubMed ID: 26785864
[TBL] [Abstract][Full Text] [Related]
11. Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence.
Clark NC; Pru CA; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2017 Mar; 158(3):640-651. PubMed ID: 28005395
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
13. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of proliferation of granulosa and Leydig cell lines derived from gonadal tumors of transgenic mice expressing the inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.
Rilianawati ; Rahman NA; Huhtaniemi I
Mol Cell Endocrinol; 1999 Mar; 149(1-2):9-17. PubMed ID: 10375013
[TBL] [Abstract][Full Text] [Related]
15. Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.
Sabbir MG
J Steroid Biochem Mol Biol; 2019 Jul; 191():105376. PubMed ID: 31067491
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
17. Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component 1 Expression in Fetal Membrane Cells.
Meng Y; Murtha AP; Feng L
Reprod Sci; 2016 Sep; 23(9):1168-78. PubMed ID: 26919974
[TBL] [Abstract][Full Text] [Related]
18. Conditional Ablation of Progesterone Receptor Membrane Component 1 Results in Subfertility in the Female and Development of Endometrial Cysts.
McCallum ML; Pru CA; Niikura Y; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2016 Sep; 157(9):3309-19. PubMed ID: 27309940
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor-NFκB complex formation is required for progesterone-induced NFκB nuclear translocation and binding onto the p53 promoter.
Hsu SP; Yang HC; Kuo CT; Wen HC; Chen LC; Huo YN; Lee WS
Endocrinology; 2015 Jan; 156(1):291-300. PubMed ID: 25353185
[TBL] [Abstract][Full Text] [Related]
20. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling.
Zhu X; Han Y; Fang Z; Wu W; Ji M; Teng F; Zhu W; Yang X; Jia X; Zhang C
Oncol Rep; 2013 Nov; 30(5):2488-94. PubMed ID: 23970345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
